Evaluating outcomes of endoscopic treatment for gastrointestinal lesions
Clinical Outcomes of the Endoscopic Resection of Premalignant and Malignant Gastrointestinal Lesions
This study tests how well endoscopic treatment works for patients with potentially harmful gastrointestinal growths and looks at safety and survival rates after the procedure.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 8000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | California Pacific Medical Center Research Institute Academic / other |
| Locations | 1 site (San Francisco, California) |
| Trial ID | NCT01750619 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess the clinical outcomes for patients undergoing endoscopic resection of suspected premalignant and malignant gastrointestinal lesions at Interventional Endoscopy Services. The primary focus is on achieving curative endoscopic resection, while secondary outcomes include the techniques used for resection, rates of en bloc resection, and the incidence of adverse events such as infection, bleeding, perforation, and mortality, along with one-year survival rates. The study will gather data from patients referred for this specific treatment to evaluate effectiveness and safety.
Who should consider this trial
Good fit: Ideal candidates are patients over 18 years old referred for endoscopic treatment of gastrointestinal lesions.
Not a fit: Patients for whom endoscopic treatment was not performed will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve treatment strategies and outcomes for patients with gastrointestinal neoplasms.
How similar studies have performed: Other studies have shown success with similar endoscopic approaches for gastrointestinal lesions, indicating potential for positive outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients age \>18 years that have been referred for endoscopic treatment of GI lesions. Exclusion Criteria: * Patients for whom endoscopic treatment was not performed.
Where this trial is running
San Francisco, California
- Interventional Endoscopy Services — San Francisco, California, United States (Recruiting)
Study contacts
- Principal investigator: Kenneth F Binmoeller, M.D. — California Pacific Medical Center
- Study coordinator: Jona C Bernabe
- Email: jona.bernabe@sutterhealth.org
- Phone: 415-600-1151
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.